Top

Gepubliceerd in:

01-03-2014 | Middelen

Nicotine: farmacologische en toxicologische aspecten

Auteurs: Dr. Raymond Niesink, Dr. Esther Croes

Gepubliceerd in: Verslaving | Uitgave 1/2014

Samenvatting

Dat roken een belangrijke risicofactor is voor morbiditeit en mortaliteit kan als bekend worden verondersteld. Toch rookt ongeveer een kwart van de volwassen Nederlanders, want roken is een zeer verslavende gewoonte. Dat hoge verslavingspotentieel kan voor een substantieel deel worden toegeschreven aan de stof nicotine. Nicotine is niet de enige stof in tabak: in tabaksrook zijn zo’n vierduizend chemische verbindingen geïdentificeerd, waaronder vele stoffen met giftige en carcinogene werking.

vorige artikel Een verslaafde met autisme

volgende artikel De cliëntenbeweging in de verslavingszorg groeit

Benowitz, N.L. & Gourlay S.G. (1997). Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. Journal of the American College of Cardiology, 29, 1422–1431.PubMedCrossRef

Benowitz, N.L. (2003). Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment. Progress in Cardiovascular Diseases, 46, 91–111.PubMedCrossRef

Benowitz, N.L. (2009). Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annual Reviews in Pharmacology and Toxicology, 49, 57–71.CrossRef

Benowitz, N.L. (2010). Nicotine addiction. New England Journal of Medicine, 362, 2295–2303.PubMedCentralPubMedCrossRef

Cohen, G., Roux, J.C., Grailhe, R., Malcolm, G., Changeux, J.P. & Lagercrantz, H. (2005). Perinatal exposure to nicotine causes deficits associated with a loss of nicotinic receptor function. Proceedings of the National Acadademy of Science USA, 102, 3817–3821.

Cooke, J.P. & Bitterman, H. (2004). Nicotine and angiogenesis: a new paradigm for tobacco-related diseases. Annals of Medicine, 36, 33–40.PubMedCrossRef

Eliasson, B. (2003). Cigarette smoking and diabetes. Progress in Cardiovascular Disease, 45, 405–413.CrossRef

Foulds, J., Stapleton, J., Swettenham, J., Bell, N., McSorley, K. & Russell, M.A. (1996). Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers. Psychopharmacology (Berl), 127, 31–38.CrossRef

Foulds, J., Stapleton, J.A., Bell, N., Swettenham, J., Jarvis, M.J. & Russell, M.A. (1997). Mood and physiological effects of subcutaneous nicotine in smokers and never-smokers. Drug and Alcohol Dependence, 14, 105–115.CrossRef

Harvey, D.M., Yasar, S., Heishman, S.J., Panlilio, L.V., Henningfield, J.E. & Goldberg, S.R. (2004). Nicotine serves as an effective reinforcer of intravenous drug-taking behavior in human cigarette smokers. Psychopharmacology (Berl), 175, 134–142.CrossRef

Hecht, S.S. (1999). Tobacco smoke carcinogens and lung cancer. Journal of the National Cancer Institute, 21, 1194–1210.CrossRef

Henley, S.J., Connell, C.J., Richter, P., Husten, C., Pechacek, T., e.a. 2007. Tobacco-related disease mortality among men who switched from cigarettes to spit tobacco. Tobacco Control, 16, 22–28.PubMedCentralPubMedCrossRef

Hoffmann, D. & Hoffmann, I. (1997). The changing cigarette, 1950-1995. Journal of Toxicology and Environmental Health, 50, 307–364.PubMedCrossRef

Joseph, A.M., Norman, S.M., Ferry, L.H., Prochazka, A.V., Westman, E.C., e.a. (1996). The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. New England Journal of Medicine, 335, 1792–1798.PubMedCrossRef

Kalman, D. (2002). The subjective effects of nicotine: methodological issues, a review of experimental studies, and recommendations for future research. Nicotine and Tobacco Research, 4, 25–70.PubMedCrossRef

Luo, J., Ye, W., Zendehdel, K., Adami, J., Adami, H.O., e.a. (2007). Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study. Lancet, 369, 2015–2020.PubMedCrossRef

Malizia, E., Andreucci, G., Alfani, F., Smeriglio, M. & Nicholai, P. (1983). Acute intoxication with nicotine alkaloids and cannabinoids in children from ingestion of cigarettes. Human Toxicology, 2, 315–316.PubMedCrossRef

Mayer, B. (2014). How much nicotine kills a human? Tracing back the generally accepted lethal dose to dubious self-experiments in the nineteenth century. Archives in Toxicology, 88, 5–7.CrossRef

Murray, R.P., Bailey, W.C., Daniels, K., Bjornson, W.M., Kurnow, K., Connett, J.E., Nides, M.A. & Kiley, J.P. (1996). Safety of nicotine polacrilex gum used by 3,094 participants in the Lung Health Study. Lung Health Study Research Group. Chest, 109, 438–445.PubMedCrossRef

National Institute for Occupational Safetv and Health (2000). Registry of toxic effects of chemical substances, NIOSH, Cincinnati. (CD-ROM version.) Denver: Micromedex.

Pidoplichko, V.I., DeBiasi, M., Williams, J.T. & Dani, J.A. (1997). Nicotine activates and desensitizes midbrain dopamine neurons. Nature, 27, 401–404.

Puranik, R. & Celermajer, D.S. (2003). Smoking and endothelial function. Progress in Cardiovascular Disease, 45, 443–458.CrossRef

Sherwood, N. (1993). Effects of nicotine on human performance. Human Psychopharmacology, 8, 155–184.CrossRef

Spindel, E.R. (2009). Is nicotine the estrogen of lung cancer? American Journal of Respiratory Critical Care Medicine, 15, 1081–1082.CrossRef

Tyndale, R.F. & Sellers, E.M. (2002). Genetic variation in CYP2A6-mediated nicotine metabolism alters smoking behavior. Therapeutic Drug Monitoring, 24, 163–171.PubMedCrossRef

Vleeming, W., Schenk, E. & Opperhuizen, A. (2005). Van tabakszaad naar tabaksrook. In K. Knol, C. Hilvering, D.J.Th. Wagener & M.C. Willemsen (red.), Tabaksgebruik: gevolgen en bestrijding (pp. 27–41). Utrecht: Lemma.

Warren, G.W. & Singh, A.K. (2013). Nicotine and lung cancer. Journal of Carcinogenesis, 31, 1.CrossRef

Wennberg, P., Eliasson, M., Hallmans, G., Johansson, L., Boman, K. & Jansson, J.H. (2007). The risk of myocardial infarction and sudden cardiac death amongst snuff users with or without a previous history of smoking. Journal of Internal Medicine, 262, 360–367.PubMedCrossRef

Zeidler, R., Albermann, K. & Lang, S. (2007). Nicotine and apoptosis. Apoptosis, 12, 1927–1943.PubMedCrossRef

Titel: Nicotine: farmacologische en toxicologische aspecten
Auteurs: Dr. Raymond Niesink
Dr. Esther Croes
Publicatiedatum: 01-03-2014
Uitgeverij: Bohn Stafleu van Loghum
Gepubliceerd in: Verslaving / Uitgave 1/2014
Print ISSN: 1574-1842
Elektronisch ISSN: 1875-7073
DOI: https://doi.org/10.1007/s12501-014-0007-5

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Samenvatting

Log in om toegang te krijgen

Andere artikelen Uitgave 1/2014

Leer van de somatiek!

Findings

Een verslaafde met autisme

Redactioneel

De cliëntenbeweging in de verslavingszorg groeit

ASS en verslaving